Free GLP-1 tool
GLP-1 Injection Site Rotation Planner
Rotate among the official injection regions for the device in your hand. The planner does not add sites or choose a preferred one.
What this result means
Organize labeled abdomen, thigh, and upper-arm sites for a supported injection presentation — without inventing extra locations.
Only abdomen, thigh, and upper arm are encoded. Site rules are presentation-specific, not shared by active ingredient. Wegovy and Ozempic single-dose syringes keep the upper arm assisted-only. Wegovy single-dose pen, Wegovy FlexTouch, and Ozempic multi-dose pen do not impose an assisted-only upper-arm limit because the current presentation IFUs do not state one. Zepbound and Mounjaro presentations keep the back of the upper arm assisted-only. The planner requires self vs assisted administration, excludes assisted-only sites for the next self-injection, and still organizes a next usable labeled site if the previous injection used an assisted region. Left/right is an organizer convenience within a labeled region. The planner never adds unofficial locations such as the buttocks.
What this tool cannot tell you
- To inject in a location that is not on the official label.
- Which side or region is medically best for you.
- Whether to change dose, timing, or medication.
Methodology & sources
Only abdomen, thigh, and upper arm are encoded. Site rules are presentation-specific, not shared by active ingredient. Wegovy and Ozempic single-dose syringes keep the upper arm assisted-only. Wegovy single-dose pen, Wegovy FlexTouch, and Ozempic multi-dose pen do not impose an assisted-only upper-arm limit because the current presentation IFUs do not state one. Zepbound and Mounjaro presentations keep the back of the upper arm assisted-only. The planner requires self vs assisted administration, excludes assisted-only sites for the next self-injection, and still organizes a next usable labeled site if the previous injection used an assisted region. Left/right is an organizer convenience within a labeled region. The planner never adds unofficial locations such as the buttocks.
- WEGOVY (semaglutide) injection / tablet prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · 2026-06 · Last verified 2026-09-16
Used for Wegovy injection missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection). Tablet rules are not encoded.
- OZEMPIC (semaglutide) injection prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · Last verified 2026-09-16
Used for Ozempic missed-dose, labeled weekly schedule, pen/syringe storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 weeks after the last dose; steady state after 4 to 5 weekly doses).
- ZEPBOUND (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Zepbound missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-to-6-day half-life; steady state after 4 weekly doses).
- MOUNJARO (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Mounjaro missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-day half-life; steady state after 4 weekly doses).
Related WellForm MD resources
Need individualized guidance?
These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.
Book a free consultation